Post-Operative Delirium in Elderly Surgical Patients (STRIDE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00590707 |
Recruitment Status :
Completed
First Posted : January 11, 2008
Results First Posted : June 11, 2018
Last Update Posted : June 11, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hip Fractures Delirium | Device: Deeper sedation Device: Moderate sedation | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 200 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | A Strategy to Reduce the Incidence of Post-Operative Delirium in Elderly Patients |
Study Start Date : | January 2005 |
Actual Primary Completion Date : | May 2017 |
Actual Study Completion Date : | May 2017 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Deeper sedation
Patients randomly assigned to this arm will receive enough sedative drugs to keep their level of awareness during the hip fracture repair, as measured by the use of the Observer's Assessment of Awareness/Sedation Scale (OAA/S), at an OAA/S score of 0. This is the "deeper sedation" arm.
|
Device: Deeper sedation
The depth of sedation, as measured by the use of the Observer's Assessment of Awareness/Sedation Scale (OAA/S), will be maintained at an OAA/S score of 0.
Other Name: Observer's Assessment of Awareness/Sedation Scale (OAA/S) |
Active Comparator: Moderate sedation
Patients randomly assigned to this arm will receive enough sedative drugs to keep their level of awareness during the hip fracture repair, as measured by the use of the Observer's Assessment of Awareness/Sedation Scale (OAA/S), at an OAA/S score of 4-5. This is the "moderate sedation" arm.
|
Device: Moderate sedation
The depth of sedation, as measured by the use of the Observer's Assessment of Awareness/Sedation Scale (OAA/S), will be maintained at an OAA/S score of 4-5.
Other Name: Observer's Assessment of Awareness/Sedation Scale (OAA/S) |
- Number of Participants With the Presence of Delirium as Assessed by the Confusion Assessment Method [ Time Frame: Postoperative days up to hospital discharge ]The presence of delirium is assessed by the confusion assessment method (CAM), during postoperative Day 1 to Day 5 or up to hospital discharge, whichever occurs first. The CAM consists of 4 features: 1-Onset, 2-Inattention, 3-Disorganized thinking, and 4-altered level of consciousness. The diagnosis of delirium by CAM is based on the presence of features 1 and 2, and either 3 or 4.
- Change in Functional Status [ Time Frame: 12 months post-operative ]Ability to perform Activities of Daily Living (ADL) using 6-point Katz activities of daily living scale, assessed at 12 months post-op. The range of the Katz activities of daily living scale is from 0-6, 0 is worse and 6 is best.
- Mortality [ Time Frame: 12 months post-operative ]death occurring during follow-up period, in one year post-op.
- Number of Participants With the Presence of Delirium at 1 Month as Assessed by the Confusion Assessment Method [ Time Frame: 1 month (30 days) post-intervention ]The presence of delirium is assessed by the confusion assessment method (CAM), after 1 month postoperative. The CAM consists of 4 features: 1-Onset, 2-Inattention, 3-Disorganized thinking, and 4-altered level of consciousness. The diagnosis of delirium by CAM is based on the presence of features 1 and 2, and either 3 or 4.
- Clinical Dementia Rating Sum of Boxes (CDR-SOB) Score [ Time Frame: 12 months post-operative ]Clinical Dementia Rating consists of 6 domains ("boxes") of function: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Each domain ("box") is rated on a 5-point scale (0= no impairment, 0.5=questionable impairment, 1= mild impairment, 2= moderated impairment, 3= severe impairment. The CDR-SOB score is a sum of these ratings, for a total Sum of boxes ranging from 0-18, where 0=cognitively intact. Increasing sum of boxes score is associated with greater cognitive impairment.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- is 65 years of age or older at admission;
- has surgical treatment of a traumatic hip fracture;
- has participating surgeon;
- has Mini-Mental Status Exam score of 15 or higher;
- able to read/write/speak/hear/understand English;
- gives informed consent;
- receives spinal anesthesia
Exclusion Criteria:
- receives general anesthesia;
- does not write/write/speak/hear/understand English;
- has severe chronic obstructive pulmonary disease (COPD);
- has severe congestive heart failure (CHF);
- has Mini-Mental Status Exam score less than 15;
- declines to give informed consent;
- age less than 65 years at admission;
- attending surgeon does not participate in study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00590707
United States, Maryland | |
The Johns Hopkins Bayview Medical Center | |
Baltimore, Maryland, United States, 21224 |
Principal Investigator: | Frederick E. Sieber, MD | Dept. of Anesthesiology and Critical Care Medicine, School of Medicine, The Johns Hopkins University |
Documents provided by Johns Hopkins University:
Responsible Party: | Johns Hopkins University |
ClinicalTrials.gov Identifier: | NCT00590707 |
Other Study ID Numbers: |
NA_00041873 ACCM Delirium 3 R01AG033615 ( U.S. NIH Grant/Contract ) |
First Posted: | January 11, 2008 Key Record Dates |
Results First Posted: | June 11, 2018 |
Last Update Posted: | June 11, 2018 |
Last Verified: | May 2018 |
Product Manufactured in and Exported from the U.S.: | No |
Hip fractures Femoral neck fractures Trochanteric fractures Intertrochanteric fractures |
Subtrochanteric fractures Delirium Confusion |
Delirium Emergence Delirium Hip Fractures Fractures, Bone Wounds and Injuries Confusion Neurobehavioral Manifestations Neurologic Manifestations |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Femoral Fractures Hip Injuries Leg Injuries Postoperative Complications Pathologic Processes |